CMPX
Compass Therapeutics Inc.
1.10$
-3.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | -1.1% | +0.6% | -0.2% | -22.8% | +1.4% | -162.1% | – | -364.4% | – | -300.0% | – | |
| – | -1.5% | +25.2% | +5.9% | +3.6% | +1.8% | +12.3% | +11.0% | -55.6% | +47.4% | +178.0% | -4.9% | – | |
| – | -107.1% | – | – | -740.0% | – | -85.3% | +863.3% | -56.6% | -32.8% | -386.2% | – | – | |
| – | -10.0% | -100.0% | – | – | -100.0% | – | -100.0% | – | -100.0% | – | +114.6% | – | |
| – | -63.0% | -164.9% | – | +347.6% | -47.0% | -24.6% | -154.9% | +1,396.2% | -96.5% | – | -113.0% | – | |
| – | – | -14.5% | – | – | – | – | – | – | – | – | – | – | |
| – | -852.4% | – | -100.0% | -300.0% | +4,600.0% | +767.0% | -100.0% | – | -99.2% | +216.6% | -214.5% | – | |
| – | -155.6% | – | – | – | -66.0% | -139.8% | – | – | -166.7% | – | -190.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.